Risk of major cardiovascular events and all-cause death in patients with bronchiectasis and associated resistance to antimicrobial drugs
In patients with bronchiectasis, AMR is associated with an increased risk of MACE and all-cause death, suggesting that controlling AMR spread may confer broader health benefits, particularly in reducing cardiovascular risk.
Authors
- Tommaso Bucci (ORCID: https://orcid.org/0000-0003-2895-6234)
- Freddy Frost (ORCID: https://orcid.org/0000-0002-3902-6502)
- Gregory Y.H. Lip (ORCID: https://orcid.org/0000-0002-7566-1626)
- Ran Guo (ORCID: https://orcid.org/0000-0002-9424-8140)
- Kai Hang Yiu (ORCID: https://orcid.org/0000-0003-2145-3108)
Institutions
- Medical University of Białystok (PL)
- University of Liverpool (GB)
- Liverpool Heart and Chest Hospital (GB)
- Liverpool John Moores University (GB)
- Sapienza University of Rome (IT)
- University of Hong Kong (HK)
- Aalborg University (DK)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-03-02
- DOI
- https://doi.org/10.1093/eurjpc/zwaf122
- Citations
- 1
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.52